John R. Moore - Oct 3, 2022 Form 4 Insider Report for Edgewise Therapeutics, Inc. (EWTX)

Role: General Counsel
Signature: /s/ John R. Moore
Stock symbol: EWTX
Transactions as of: Oct 3, 2022
Transactions value $: -$37,026
Form type: 4
Date filed: 10/5/2022, 04:42 PM
Previous filing: Sep 8, 2022
Next filing: May 3, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EWTX	Common Stock	Options Exercise	$9.13K	+4.73K	+157.67%	$1.93	7.73K	Oct 3, 2022	Direct
transaction	EWTX	Common Stock	Sale	-$46.2K	-4.73K	-61.19%	$9.76	3K	Oct 3, 2022	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	EWTX	Stock Option (Right to Buy)	Options Exercise	$0	-4.73K	-3.7%	$0.00	123K	Oct 3, 2022	Common Stock	4.73K	$1.93	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on March 16, 2022.
F2	The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $9.47 to $10.00, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3	1/48th of the shares subject to the option vest each month beginning on January 3, 2021, subject to the Reporting Person continuing as a service provider through each vest date.